Contact Us

DESTINATION NEWS

Ractigen Therapeutics Announces U.S. FDA Orphan Drug Designation (ODD) granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy

Aug 27, 2024

NANTONG and SUZHOU,China,Aug. 22,2024-- Ractigen Therapeutics,a pioneering developer of small activating RNA (saRNA) therapeutics,today announced that the U.S. Food and Drug Administration (FDA) has g

Mega Matrix Announces That the Romantic Short Drama "Before the Divorce: My CEO Husband Can't Get Enough of Me" Will Be Released on August 22 at FlexTV

Aug 27, 2024

PALO ALTO,Calif.,Aug. 22,2024-- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU),today announced that it launched its romantic short drama "Before the Divorce:

Zhihu Inc. Reports Unaudited Second Quarter 2024 Financial Results

Aug 27, 2024

BEIJING,Aug. 23,2024-- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390),a leading online content community in China,today announced its unaudited financial results for

Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But Condemns Decision to Deny NHS Access

Aug 27, 2024

CHICAGO,Aug. 23,2024-- The Alzheimer\'s Association welcomes today\'s decision by the United Kingdom\'s Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqembi® (lecanemab)

Dongying marks milestone with first World Natural Heritage

Aug 27, 2024

DONGYING,China,Aug. 22,2024-- A news report from chinadaily.com.cn: The Yellow River estuary migratory bird sanctuary in Dongying,Shandong province,gained world-class status when it was named a Natura

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Aug 27, 2024

Today,Getinge announces an agreement to acquire 100% of Paragonix Technologies,Inc.,a leading organ transport products and services company in the United States for an aggregated purchase price,includ

1 ... 308 309 310 311 312 313 314 ... 353